A Phase I/IIa multi-dose escalation study of BT062 in combination with Lenalidomide and Dexamethasone in subjects with relapsed or relapsed/refractory Multiple Myeloma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I/IIa multi-dose escalation study of BT062 in combination with Lenalidomide and Dexamethasone in subjects with relapsed or relapsed/refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma
Locations
Hackensack
Sponsor
Biotest 983
Protocol Number
Biotest 983
Cancer Diagnosis
To Learn More Call
201-510-0910